Mukumbwa-Mwenechanya Mpande, Mubiana Muhau, Somwe Paul, Zyambo Khozya, Simwenda Maureen, Zongwe Nancy, Kalunkumya Estella, Mwango Linah Kampilimba, Rabkin Miriam, Mpesela Felton, Chungu Fred, Mwanza Felix, Preko Peter, Bolton-Moore Carolyn, Bosomprah Samuel, Sharma Anjali, Morton Khunga, Kasonde Prisca, Mulenga Lloyd, Lingu Patrick, Mulenga Priscilla Lumano
Centre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Ministry of Health, Lusaka, Zambia.
PLOS Glob Public Health. 2023 Mar 8;3(3):e0000909. doi: 10.1371/journal.pgph.0000909. eCollection 2023.
Most people living with HIV (PLHIV) established on treatment in Zambia receive multi-month prescribing and dispensing (MMSD) antiretroviral therapy (ART) and are enrolled in less-intensive differentiated service delivery (DSD) models such as Fast Track (FT), where clients collect ART every 3-6 months and make clinical visits every 6 months. In 2019, Zambia introduced Isoniazid Preventive Therapy (IPT) with scheduled visits at 2 weeks and 1, 3, and 6 months. Asynchronous IPT and HIV appointment schedules were inconvenient and not client centered. In response, we piloted integrated MMSD/IPT in FT HIV treatment model. We implemented and evaluated a proof-of-concept project at one purposively selected high-volume facility in Lusaka, Zambia between July 2019 and May 2020. We sensitized stakeholders, adapted training materials, standard operating procedures, and screened adults in FT for TB as per national guidelines. Participants received structured TB/IPT education, 6-month supply of isoniazid and ART, aligned 6th month IPT/MMSD clinic appointment, and phone appointments at 2 weeks and months 1-5 following IPT initiation. We used descriptive statistics to characterize IPT completion rates, phone appointment keeping, side effect frequency and Fisher's exact test to determine variation by participant characteristics. Key lessons learned were synthesized from monthly meeting notes. 1,167 clients were screened with 818 (70.1%) enrolled, two thirds (66%) were female and median age 42 years. 738 (90.2%) completed 6-month IPT course and 66 (8.1%) reported IPT-related side effects. 539 clients (65.9%) attended all 7 telephone appointments. There were insignificant differences of outcomes by age or sex. Lessons learnt included promoting project ownership, client empowerment, securing supply chain, adapting existing processes, and cultivating collaborative structured learning. Integrating multi-month dispensing and telephone follow up of IPT into the FT HIV treatment model is a promising approach to scaling-up TB preventive treatment among PLHIV, although limited by barriers to consistent phone access.
赞比亚大多数接受治疗的艾滋病毒感染者(PLHIV)采用多月份开方与配药(MMSD)的抗逆转录病毒疗法(ART),并纳入了强度较低的差异化服务提供(DSD)模式,如快速通道(FT)模式,即患者每3至6个月领取一次抗逆转录病毒药物,每6个月进行一次临床检查。2019年,赞比亚引入了异烟肼预防性治疗(IPT),安排在第2周以及第1、3和6个月进行随访。IPT和艾滋病毒诊疗预约时间不同步,给患者带来不便,且并非以患者为中心。作为应对措施,我们在FT艾滋病毒治疗模式中试点了综合MMSD/IPT。2019年7月至2020年5月期间,我们在赞比亚卢萨卡一个经过特意挑选的高流量医疗机构实施并评估了一个概念验证项目。我们提高了利益相关者的认识,调整了培训材料、标准操作程序,并按照国家指南对FT模式下的成年人进行结核病筛查。参与者接受了结构化的结核病/IPT教育,领取了6个月用量的异烟肼和抗逆转录病毒药物,安排了第6个月的IPT/MMSD联合门诊预约,并在IPT开始后的第2周以及第1至5个月安排了电话预约。我们使用描述性统计来描述IPT完成率、电话预约遵守情况、副作用发生率,并使用Fisher精确检验来确定不同参与者特征之间的差异。从月度会议记录中总结出了主要经验教训。共对1167名患者进行了筛查,其中818人(70.1%)登记入组,三分之二(66%)为女性,中位年龄42岁。738人(90.2%)完成了6个月的IPT疗程,66人(8.1%)报告了与IPT相关的副作用。539名患者(65.9%)参加了所有7次电话预约。年龄或性别对结果没有显著差异。经验教训包括促进项目自主性、增强患者权能、确保供应链、调整现有流程以及培养协作式结构化学习。将IPT的多月份配药和电话随访纳入FT艾滋病毒治疗模式,是扩大对PLHIV结核病预防性治疗规模的一种有前景的方法,尽管受到电话持续接入障碍的限制。